Current trends in the treatment of asthma

Focus on the simultaneous administration of salmeterol/fluticasone

Robyn Teply, Jennifer Campbell, Daniel E. Hilleman

Research output: Contribution to journalReview article

Abstract

Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalJournal of Asthma and Allergy
Issue number3
StatePublished - 2010

Fingerprint

Asthma
Adrenal Cortex Hormones
Nebulizers and Vaporizers
Edema
Chronic Disease
Anti-Inflammatory Agents
Salmeterol Xinafoate Drug Combination Fluticasone Propionate
Inflammation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Current trends in the treatment of asthma : Focus on the simultaneous administration of salmeterol/fluticasone. / Teply, Robyn; Campbell, Jennifer; Hilleman, Daniel E.

In: Journal of Asthma and Allergy, No. 3, 2010, p. 1-8.

Research output: Contribution to journalReview article

@article{bb4c147f565544388bb5895cfa9eb3d2,
title = "Current trends in the treatment of asthma: Focus on the simultaneous administration of salmeterol/fluticasone",
abstract = "Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy.",
author = "Robyn Teply and Jennifer Campbell and Hilleman, {Daniel E.}",
year = "2010",
language = "English",
pages = "1--8",
journal = "Journal of Asthma and Allergy",
issn = "1178-6965",
publisher = "Dove Medical Press Ltd.",
number = "3",

}

TY - JOUR

T1 - Current trends in the treatment of asthma

T2 - Focus on the simultaneous administration of salmeterol/fluticasone

AU - Teply, Robyn

AU - Campbell, Jennifer

AU - Hilleman, Daniel E.

PY - 2010

Y1 - 2010

N2 - Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy.

AB - Asthma is a chronic disease of the airways that affects over 20 million people in the United States. It is a complex disease that involves airway infiltration by different types of cells and cell mediators causing chronic inflammation of the airway as well as hyper-responsiveness and edema. Management of asthma symptoms often requires combination therapy with multiple medications. Long-acting beta-2 agonists and inhaled corticosteroids have become key medications in the prevention of asthma exacerbations. The bronchodilatory effects of the beta-2 agonists coupled with the anti-inflammatory action of the corticosteroids combat the multi-factorial causes of asthma. The combination inhaler containing salmeterol and fluticasone is one such product that has been proven safe and effective for asthma therapy.

UR - http://www.scopus.com/inward/record.url?scp=77953469231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953469231&partnerID=8YFLogxK

M3 - Review article

SP - 1

EP - 8

JO - Journal of Asthma and Allergy

JF - Journal of Asthma and Allergy

SN - 1178-6965

IS - 3

ER -